Author Correction: Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Saved in:
Main Authors: | Shivshankar Thanigaimani, James Phie, Smriti Murali Krishna, Joseph Moxon, Jonathan Golledge |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7d828e3a20df4a67bf0f5dc28073699e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
by: Shivshankar Thanigaimani, et al.
Published: (2021) -
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
by: Gian Luca Erre, et al.
Published: (2019) - Rheumatic Fever & Rheumatic Heart Disease
-
Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
by: Imperiali Claudia E., et al.
Published: (2020) -
Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
by: Fang-Ju Lin, et al.
Published: (2017)